Last-resort drug offered to teens with untreatable stomach pain
NCT ID NCT04699591
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program gives domperidone to teenagers aged 12 to 21 who have severe stomach or reflux problems that haven't gotten better with standard treatments. The goal is to see if the drug can reduce their symptoms. Up to 20 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Mercy Hospitals and Clinics
RECRUITINGKansas City, Missouri, 64108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Could a botox shot in the gut ease Kids' chronic vomiting?
- Zapping the esophagus: an implantable device takes on chronic heartburn
- Could a simple probe placement change improve GERD diagnosis for millions?
- Can writing poetry ease anxiety for those with stomach disorders?
- Could a simple neck band protect transplanted lungs from stomach acid?